Viewing Study NCT01729559

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:50 PM
Ignite Modification Date: 2026-03-09 @ 12:20 AM
Study NCT ID: NCT01729559
Status: COMPLETED
Last Update Posted: 2016-07-18
First Post: 2012-11-14
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
Sponsor: Scripps Health
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolic Disease View
None Deep Vein Thrombosis View
None Pulmonary Embolism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None venous thromboembolic disease View
None deep vein thrombosis View
None pulmonary embolism View
None trauma View
None antithrombotic prophylaxis View